Sangamo signs agreement with Prevail to study AAV capsids
Prevail will perform in vitro and in vivo studies on some of the adeno-associated virus capsids of Sangamo. Credit: Kateryna Kon/Shutterstock.com. Sangamo Therapeutics has signed
Prevail will perform in vitro and in vivo studies on some of the adeno-associated virus capsids of Sangamo. Credit: Kateryna Kon/Shutterstock.com. Sangamo Therapeutics has signed
The collaboration intends to find new oligonucleotides optimised for safety, efficacy and delivery. Credit: Tatiana from Pixabay. Elsie Biotechnologies has signed a research collaboration agreement
Just – Evotec Biologics will focus on developing drug product prototypes from the discovery stage to the launch of first-in-human Phase I clinical trials. Credit: